Corticosteroids alone

Phase 3Small molecule

MMansoura University

Corticosteroids alone is one of 68 small molecule programs targeting Venous thrombosis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Venous ThrombosisActive, not recruiting

Pulmonary FibrosisActive, not recruiting

Venous ThrombosisPhase 3

Active, not recruiting

Pulmonary FibrosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

50 competitors in Venous Thrombosis

#DrugCompanyPhaseTrials

Eliquis

Bristol-Myers Squibb

Approved

6 2

Bayer Aspirin

Bayer

Approved

—3

Arixtra

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Lovenox

3 5

Innohep

Alnylam Pharmaceuticals

Phase 3

2 6

Xarelto

WWim Janssens

Phase 3

11 7

Coumadin

AAbbott

Phase 3

7 8

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

—9

Anticoagulation

HHospital Álvaro Cunqueiro

Approved

1 10

Acenocoumarol

Roche

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Phase 3Not yet recruiting

Venous Thrombosis

NCT06780462

Clinical

Trials by Indication[1]

Venous thrombosis1 trial

Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT06780462·134 enrolled

Pulmonary Fibrosis1 trial

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Completed·MMansoura University··NCT05648734·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Corticosteroids alone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Corticosteroids alone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Corticosteroids alone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mansoura University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: MMansoura University

Corticosteroids alone

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Venous thrombosis1 trial

Pulmonary Fibrosis1 trial

References

Drug Info

Quick Facts

Related News